StockData
MoonLake Immunotherapeutics logo

MoonLake Immunotherapeutics (MLTX) stock

MLTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$10.79−0.46 (-4.09%)

Close on Nov 18, 2026Market cap $918.30MP/E –Yield –

MoonLake Immunotherapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

MoonLake Immunotherapeutics's pe ratio was 255.5× on Oct 31, 2022.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Oct 31, 2022255.5×–

More MoonLake Immunotherapeutics figures

See a number that looks wrong?